Reviewing Exela Technologies (NASDAQ:XELA) and Phreesia (NASDAQ:PHR)

Exela Technologies (NASDAQ:XELA) and Phreesia (NYSE:PHR) are both small-cap business services companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, valuation, earnings, profitability, analyst recommendations, risk and institutional ownership.


This table compares Exela Technologies and Phreesia’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Exela Technologies -17.99% N/A -8.10%
Phreesia N/A N/A N/A

Valuation and Earnings

This table compares Exela Technologies and Phreesia’s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Exela Technologies $1.59 billion 0.03 -$162.52 million ($0.77) -0.37
Phreesia N/A N/A N/A N/A N/A

Phreesia has lower revenue, but higher earnings than Exela Technologies.

Analyst Recommendations

This is a summary of recent ratings and price targets for Exela Technologies and Phreesia, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Exela Technologies 0 1 3 0 2.75
Phreesia 0 0 6 0 3.00

Exela Technologies currently has a consensus price target of $6.00, indicating a potential upside of 2,000.84%. Phreesia has a consensus price target of $30.60, indicating a potential upside of 8.82%. Given Exela Technologies’ higher possible upside, equities research analysts clearly believe Exela Technologies is more favorable than Phreesia.

Insider and Institutional Ownership

45.0% of Exela Technologies shares are held by institutional investors. Comparatively, 49.9% of Phreesia shares are held by institutional investors. 53.1% of Exela Technologies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.


Phreesia beats Exela Technologies on 5 of the 8 factors compared between the two stocks.

About Exela Technologies

Exela Technologies, Inc. (Exela), formerly Quinpario Acquisition Corp. 2, is engaged in providing information and transaction processing solutions. The Company’s segments include Information and Transaction Processing Solutions (ITPS), Healthcare Solutions (HS) and Legal & Loss Prevention Services (LLPS). ITPS provides industry solutions for banking and financial services, including lending solutions for mortgages, banking solutions for clearing, anti-money laundering, sanctions, cross-border settlement; property and casualty insurance solutions for enrollments, and communications. The HS segment offerings include integrated accounts payable and accounts receivable, and information management for both the healthcare payer and provider markets. The LLPS segment solutions include processing of legal claims for class action and mass action settlement administrations, involving project management support, notification and collection, analysis, and distribution of settlement funds.

About Phreesia

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company's Phreesia Platform offers a suite of solutions to manage the patient intake process and an integrated payments solution for processing of patient payments. It deploys its platform in a range of modalities, including through Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a Web-based dashboard for providers; PhreesiaPads, which are self-service intake tablets; and Arrivals Stations that are on-site kiosks. The company's Phreesia Platform provides a registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, and cost estimation tools; clinical support solution that collects clinical intake and PRO data for approximately 25 specialties; appointments solution for online appointments, reminders, and referral tracking; and life sciences solution to deliver targeted and clinically relevant marketing content to patients. It serves patients, healthcare provider organizations, and life sciences companies. The company was founded in 2005 and is headquartered in New York, New York.

Receive News & Ratings for Exela Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exela Technologies and related companies with's FREE daily email newsletter.